1-4 of 4
Paolo Sportoletti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Idanna Innocenti, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Prof., Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Journal: Blood Advances
Blood Adv bloodadvances.2024013792.
https://doi.org/10.1182/bloodadvances.2024013792
Published: 2024
Includes: Supplemental data
Journal Articles

Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1 -mutated AML

Clinical Trials & Observations
Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, Francesca Rocchio, Valentina Tini, Barbara Bigerna, Paolo Sportoletti, Simona Caruso, Andrea Marra, Sara Peruzzi, Eleonora Petito, Giulio Spinozzi, Sharon Shacham, Yosef Landesman, Concetta Quintarelli, Paolo Gresele, Franco Locatelli, Maria Paola Martelli, Brunangelo Falini, Lorenzo Brunetti
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5938–5949.
https://doi.org/10.1182/bloodadvances.2022007563
Published: 2022
Includes: Supplemental data
Journal Articles

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study

Alberto Fresa, Francesco Autore, Alfonso Piciocchi, Gioacchino Catania, Andrea Visentin, Annamaria Tomasso, Marina Moretti, Candida Vitale, Annalisa Chiarenza, Francesca Morelli, Paolo Sportoletti, Roberto Marasca, Giuseppe Sapienza, Annarosa Cuccaro, Roberta Murru, Alessandro Sanna, Caterina Patti, Ilaria Angeletti, Marta Coscia, Livio Trentin, Daniela Pietrasanta, Idanna Innocenti, Luca Laurenti
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3875–3878.
https://doi.org/10.1182/bloodadvances.2022006964
Published: 2022
Includes: Supplemental data
Journal Articles

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

Clinical Trials & Observations
Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro, Annalisa Chiarenza, Marta Coscia, Stefania Ciolli, Gianluigi Reda, Luca Laurenti, Marzia Varettoni, Roberta Murru, Claudia Baratè, Paolo Sportoletti, Antonino Greco, Chiara Borella, Valentina Rossi, Marina Deodato, Annalisa Biagi, Giulia Zamprogna, Angelo Curto Pelle, Gianfranco Lapietra, Candida Vitale, Francesca Morelli, Ramona Cassin, Alberto Fresa, Chiara Cavalloni, Massimiliano Postorino, Claudia Ielo, Roberto Cairoli, Francesco Di Raimondo, Marco Montillo, Giovanni Del Poeta
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5490–5500.
https://doi.org/10.1182/bloodadvances.2021004824
Published: 2021
Includes: Supplemental data